DLBCL with amplification of JAK2/PD-L2 exhibits PMBCL-like CNA pattern and worse clinical outcome resembling those with MYD88 L265P mutation | BMC Cancer | Full Text

DLBCL with amplification of JAK2/PD-L2 exhibits PMBCL-like CNA pattern and worse clinical outcome resembling those with MYD88 L265P mutation | BMC Cancer | Full Text

DLBCL with amplification of JAK2/PD-L2 exhibits PMBCL-like CNA pattern and worse clinical outcome resembling those with MYD88 L265P mutation

Recently, copy number alteration (CNA) of 9p24.1 were demonstrated in 10% of diffuse large b-cell lymphoma (DLBCL), with gene expression and mutation profiles that were similar to those of primary mediastinal ...

Authors:Xuemin Xue, Wenting Huang, Tian Qiu, Lei Guo, Jianming Ying and Ning Lv

Citation:BMC Cancer 2020 20:816

Content type:Research article

 

Published on: 27 August 2020

• ViewFull Text
 
• ViewPDF